DMPEN
DMPEN (NSC 682691) (4-Demethylpenclomedine) is an alkylating metabolite of Penclomedine (HY-106401). DMPEN has an antitumor activity. DMPEN does not induce Purkinje cells loss with no significant neurocerebellar toxicity in rat cerebellum models. DMPEN can be used for cancers like breast and brain cancer research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 176046-79-0
- Fòrmula: C7H4Cl5NO2
- Peso molecular:311.38
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 176046-79-0
-
Peso molecular 311.38
-
Fòrmula C7H4Cl5NO2
-
SMILES
ClC1=C(OC)N=C(C(Cl)(Cl)Cl)C(Cl)=C1O
-
Synonyms
NSC 682691; 4-Demethylpenclomedine
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. O'Reilly S, et al. The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum. Invest New Drugs. 2003 Aug;21(3):269-79. [Content Brief]
[2]. Waud WR, et al. 4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res. 1997 Mar 1;57(5):815-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)